Textbook of Pharmacoepidemiology

Textbook of Pharmacoepidemiology

NOOK Book(eBook)

$76.49 $94.00 Save 19% Current price is $76.49, Original price is $94. You Save 19%.
View All Available Formats & Editions
Available on Compatible NOOK Devices and the free NOOK Apps.
LendMe® See Details
Want a NOOK ? Explore Now


Textbook of Pharmacoepidemiology by Brian L. Strom

Textbook of Pharmacoepidemiology, Second Edition, provides an introduction to pharmacoepidemiology and the data sources, methods and applications used in clinical research, the pharmaceutical industry
and regulatory agencies.

Drawing upon the fifth edition of the authoritative reference, Pharmacoepidemiology, this new edition covers the key learning requirements of the discipline. The textbook provides an introduction to
pharmacoepidemiology, pharmacoepidemiological data sources, special issues in methodology, special applications and future developments in the field. Updated learning features such as case studies, key points and Suggested Further Reading are included throughout the text.

Textbook of Pharmacoepidemiology is a practical educational resource for upper-level undergraduates, graduate students, post-doctoral fellows in schools of public health, pharmacy and medicine, and for everyone learning and working in pharmacoepidemiology.

Product Details

ISBN-13: 9781118708002
Publisher: Wiley
Publication date: 05/13/2013
Sold by: Barnes & Noble
Format: NOOK Book
Pages: 520
File size: 6 MB

About the Author

Brian L. Strom, University of Pennsylvania School of Medicine, USA. 

Stephen E. Kimmel, Associate Professor of Medicine and Epidemiology, University of Pennsylvania School of Medicine, USA.

Table of Contents

List of Contributors.



Acknowledgments from Pharmacoepidemiology, Fourth Edition.


1. What is Pharmacoepidemiology? (Brian L. Strom).

2. Study Designs Available for Pharmacoepidemiology Studies (Brian L. Strom).

3. Sample Size Considerations for Pharmacoepidemiology Studies (Brian L. Strom).

4. Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies (Sean Hennessy).

5. When Should One Perform Pharmacoepidemiology Studies? (Brian L. Strom).

6. Views from Academia, Industry, and Regulatory Agencies (Leanne K. Madre, Robert M. Califf, Robert F. Reynolds, Peter Arlett, and Jane Moseley).


7. Spontaneous Reporting in the United States (Syed Rizwanuddin Ahmad, Norman S. Marks, and Roger A. Goetsch).

8. Global Drug Surveillance: The WHO Programme for International Drug Monitoring (I. Ralph Edwards, Sten Olsson, Marie Lindquist, and Bruce Hugman).

9. Case–Control Surveillance (Lynn Rosenberg, Patricia F. Coogan, and Julie R. Palmer).

10. Prescription-Event Monitoring (Saad A.W. Shakir).

11. Overview of Automated Databases in Pharmacoepidemiology (Brian L. Strom).

12. Examples of Automated Databases (Andy Stergachis, Kathleen W. Saunders, Robert L. Davis, Stephen E. Kimmel, Rita Schinnar, K. Arnold Chan, Deborah Shatin, Nigel S.B. Rawson, Sean Hennessy, Winanne Downey, MaryRose Stang, Patricia Beck, William Osei, Hubert G. Leufkens, Thomas M. MacDonald, and Joel M. Gelfand).

13. Other Approaches to Pharmacoepidemiology Studies (Brian L. Strom).

14. How Should One Perform Pharmacoepidemiology Studies? Choosing Among the Available Alternatives (Brian L. Strom).

15. Validity of Pharmacoepidemiologic Drug and Diagnosis Data (Suzanne L. West, Brian L. Strom, and Charles Poole).


16. Bias and Confounding in Pharmacoepidemiology (Ilona Csizmadi and Jean-Paul Collet).

17. Determining Causation from Case Reports (Judith K. Jones).

18. Molecular Pharmacoepidemiology (Stephen E. Kimmel).

19. Bioethical Issues in Pharmacoepidemiologic Research (Kevin Haynes, Jason Karlawish, and Elizabeth B. Andrews).

20. The Use of Randomized Controlled Trials for Pharmacoepidemiology Studies (Samuel M. Lesko and Allen A. Mitchell).

21. The Use of Pharmacoepidemiology to Study Beneficial Drug Effects (Brian L. Strom).

22. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals (Kevin A. Schulman, Henry A. Glick, and Daniel Polsky).

23. Using Quality-of-Life Measurements in Pharmacoepidemiologic Research (Holger Schünemann, Gordon H. Guyatt, and Roman Jaeschke).

24. The Use of Meta-analysis in Pharmacoepidemiology (Carin J. Kim and Jesse A. Berlin).

25. Patient Adherence to Prescribed Drug Dosing Regimens in Ambulatory Pharmacotherapy (John Urquhart and Bernard Vrijens).

26. Novel Approaches to Pharmacoepidemiology Study Design and Statistical Analysis (Samy Suissa).


27. Special Applications of Pharmacoepidemiology (David Lee, Sumit R. Majumdar, Helene Levens Lipton, Stephen B. Soumerai, Sean Hennessy, Robert L. Davis, Robert T. Chen, Roselie A. Bright, Allen A. Mitchell, David J. Graham, David W. Bates, and Brian L. Strom).

28. The Future of Pharmacoepidemiology (Brian L. Strom and Stephen E. Kimmel).

Appendix A Sample Size Tables.

Appendix B Glossary.


Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews